Carlsmed (CARL) Retained Earnings (2024 - 2026)

Carlsmed (CARL) has reported Retained Earnings for 3 consecutive years, with $204.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Retained Earnings rose 344.05% year-over-year to $204.3 million; the trailing twelve-month figure through Jun 2026 stood at $204.3 million (up 344.05% YoY), and the FY2025 full-year result was $199.7 million, up 380.56% from the prior year.
• Retained Earnings grew to $204.3 million in Q2 2026 per CARL's latest filing, from $201.7 million in the prior quarter.
• Across five years, Retained Earnings topped out at $204.3 million in Q2 2026 and bottomed at -$83.7 million in Q2 2025.
• Historically, Retained Earnings has averaged $108.3 million across 3 years, with a median of $199.3 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Retained Earnings surged 380.56% in 2025, then jumped 344.05% in 2026.
• Over 3 years, Retained Earnings stood at -$71.2 million in 2024, then soared by 380.56% to $199.7 million in 2025, then rose by 2.3% to $204.3 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered $204.3 million, $201.7 million, and $199.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.